Medicare Enrolled
Dr. Andrew Chung, M.D.
Internal Medicine · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chung? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chung
Dr. Andrew Chung is an internal medicine in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Chung performed 16,694 Medicare services across 7,295 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chung received a total of $12,029 from 58 pharmaceutical and/or device companies across 734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chung is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in TX$ $12,029 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,694
Medicare services
Top 2% in TX for internal medicine
7,295
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~879 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 2,394 | $46 | $75 |
| Allergy immunotherapy preparation | 1,942 | $12 | $30 |
| Allergy skin test | 1,320 | $3 | $15 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 826 | $101 | $188 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 626 | $41 | $150 |
| Blood draw (venipuncture) | 540 | $8 | $22 |
| Comprehensive metabolic blood panel | 527 | $10 | $45 |
| Office visit, established patient (30-39 min) | 468 | $80 | $412 |
| Complete blood count (CBC) with differential | 451 | $8 | $45 |
| Office visit, established patient, complex (40-54 min) | 436 | $118 | $510 |
| Lipid panel (cholesterol and triglycerides) | 378 | $13 | $45 |
| Thyroid stimulating hormone (TSH) test | 366 | $16 | $90 |
| Magnesium level test | 350 | $6 | $24 |
| Bilirubin level, direct | 342 | $5 | $50 |
| Free thyroxine (T4) test | 342 | $9 | $45 |
| Thyroid hormone, t3 measurement, free | 341 | $16 | $90 |
| C-reactive protein test (inflammation marker) | 309 | $5 | $22 |
| Natriuretic peptide (heart and blood vessel protein) level | 302 | $38 | $120 |
| Cortisol (hormone) measurement, total | 297 | $16 | $99 |
| Vitamin D level test | 196 | $29 | $112 |
| Electrocardiogram (EKG), 12-lead | 170 | $11 | $45 |
| Parathyroid hormone level test | 166 | $40 | $225 |
| Phosphate level test | 166 | $5 | $18 |
| Annual wellness visit, follow-up | 165 | $128 | $243 |
| Hemoglobin A1c test (diabetes monitoring) | 158 | $9 | $38 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 145 | $26 | $56 |
| Annual depression screening | 143 | $18 | $54 |
| Drug injection, under skin or into muscle | 141 | $11 | $52 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 129 | $1 | $45 |
| Test for balance and posture | 126 | $35 | $300 |
| PSA test (prostate cancer screening) | 123 | $18 | $60 |
| Testosterone (hormone) level, total | 119 | $25 | $158 |
| Evaluation and testing for balance with recording | 118 | $87 | $300 |
| Test for abnormal eye movement using a rotating chair | 118 | $101 | $300 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 115 | $18 | $60 |
| Gonadotropin, luteinizing (reproductive hormone) level | 115 | $18 | $60 |
| Ultrasound of both sides of head and neck blood flow | 114 | $109 | $564 |
| Allergy injection therapy, multiple injections | 102 | $9 | $28 |
| Echocardiogram, transthoracic | 98 | $80 | $525 |
| Testing of autonomic (sympathetic) nervous system function | 98 | $96 | $525 |
| Chronic care management, additional 20 min/month | 98 | $34 | $75 |
| Bone density scan (DEXA) | 95 | $38 | $219 |
| Apolipoprotein level | 95 | $20 | $63 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 88 | $25 | $50 |
| Test for allergy using allergenic extract injected into skin with delayed reaction analysis | 80 | $10 | $28 |
| Office visit, established patient (20-29 min) | 74 | $58 | $270 |
| Uric acid level test | 57 | $4 | $15 |
| Vitamin B-12 level test | 56 | $15 | $45 |
| Folic acid level test | 55 | $14 | $48 |
| Test to assess balance during warm and cool irrigation in both ears | 54 | $32 | $75 |
| Flu vaccine administration | 52 | $31 | $45 |
| Complete ultrasound scan of abdomen | 48 | $64 | $548 |
| Flu vaccine, high-dose | 46 | $72 | $120 |
| Ultrasound study of arm and leg arteries | 44 | $66 | $330 |
| Ultrasound of leg arteries or artery grafts | 42 | $193 | $795 |
| Ferritin level test (iron stores) | 39 | $13 | $45 |
| Iron level test | 34 | $6 | $21 |
| Transferrin (iron binding protein) level | 34 | $12 | $42 |
| Glutamyltransferase (liver enzyme) level | 32 | $7 | $24 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 26 | $53 | $123 |
| New patient office visit, complex (60-74 min) | 24 | $143 | $660 |
| Ultrasound scan of head and neck soft tissue | 23 | $65 | $472 |
| Bladder ultrasound after voiding | 19 | $8 | $75 |
| Transitional care management services for problem of high complexity | 19 | $172 | $452 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $269 | $409 |
| Pneumonia vaccine administration | 18 | $31 | $60 |
| Test to measure expiratory airflow and volume | 16 | $21 | $80 |
| Complete ultrasound scan behind abdominal cavity | 14 | $64 | $510 |
| Administration of vaccine | 12 | $15 | $52 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
4.0% medium
95.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,029
Total received (2018-2024)
Avg $1,718/year across 7 years
Top 7% in TX for internal medicine
58
Companies
734
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,029 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,338
2023$1,085
2022$1,181
2021$1,599
2020$1,797
2019$2,460
2018$2,569
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,360
Amgen Inc.
$1,134
GlaxoSmithKline, LLC.
$1,104
Lilly USA, LLC
$886
Novo Nordisk Inc
$876
Amarin Pharma Inc.
$829
Janssen Pharmaceuticals, Inc
$720
Astellas Pharma US Inc
$553
PFIZER INC.
$550
Novartis Pharmaceuticals Corporation
$464
AbbVie Inc.
$337
SANOFI-AVENTIS U.S. LLC
$334
E.R. Squibb & Sons, L.L.C.
$284
Merck Sharp & Dohme Corporation
$193
ABBVIE INC.
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
Ironwood Pharmaceuticals, Inc
$154
IDORSIA PHARMACEUTICALS US INC
$146
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$143
Bayer HealthCare Pharmaceuticals Inc.
$131
Intersect ENT, Inc.
$124
Takeda Pharmaceuticals U.S.A., Inc.
$97
Synergy Pharmaceuticals Inc
$82
Biohaven Pharmaceutical Holding Company Ltd.
$73
Allergan, Inc.
$67
Allergan Inc.
$60
SANOFI PASTEUR INC.
$59
Gilead Sciences, Inc.
$58
Abbott Laboratories
$58
Medtronic, Inc.
$52
LINUS HEALTH, INC.
$51
IRONWOOD PHARMACEUTICALS, INC
$48
Philips North America LLC
$46
Sanofi Pasteur Inc.
$43
Radius Health, Inc.
$39
Merck Sharp & Dohme LLC
$38
Eisai Inc.
$38
Lundbeck LLC
$37
Genentech USA, Inc.
$34
CeQur Corporation
$30
Horizon Therapeutics plc
$28
Daiichi Sankyo Inc.
$28
Kowa Pharmaceuticals America, Inc.
$26
ARBOR PHARMACEUTICALS, INC.
$25
Covidien LP
$21
Catalyst Pharmaceuticals, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$20
Aerin Medical Inc.
$19
Nestle HealthCare Nutrition Inc.
$18
Recor Medical Inc
$16
Optos, Inc.
$15
Azurity Pharmaceuticals, Inc.
$14
Horizon Pharma plc
$14
Exact Sciences Corporation
$14
Smith+Nephew, Inc.
$14
Ethicon US, LLC
$12
Currax Pharmaceuticals LLC
$12
Dynavax Technologies Corporation
$11
Top 3 companies account for 29.9% of total payments
Associated products mentioned in payments ›
(CK7) Extended Holter · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREO · BREZTRI · BYDUREON · Belviq · CAMZYOS · CHANTIX · CONTRAVE · CORE COGNITIVE EVALUATION · CREON · CeQur Simplicity · Cologuard Collection Kit · DUEXIS · DUZALLO · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbyclor · FARXIGA · FASENRA · FIRDAPSE · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FreeStyle Libre · FreeStyle Libre 2 · GRAFIX PL · Heplisav-B · Horizant · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINX Reflux Management System · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · NFC-700 · NURTEC ODT · Otezla · Otovel · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROPEL · Prolia · QULIPTA · QUVIVIQ · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPRAVATO · SYMBICORT · SYNVISC-ONE · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VENASEAL · VIMOVO · VRAYLAR · VYEPTI · VYNDAQEL · Vascepa · Veozah · Victoza · VivAer · Wegovy · XARELTO · XIFAXAN · Xofluza · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in TX.
Equivalent to $72 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
2,123
Per 100K population
81.5
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chung is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chung experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Chung performed 2,394 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chung receive payments from pharmaceutical companies?
Yes. Dr. Chung received a total of $12,029 from 58 companies across 734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chung's costs compare to other internal medicines in Dallas?
Dr. Chung's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Dallas
Browse internal medicines in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in TX
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in TX
Which TX internal medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology